About 2007 people in two interviews mm
major health topics
mm how small the most cost
medicine doctor if you have had the experience, pharmacy staff to sell this and that, but you do not know which drug is more suitable Your disease; hospital doctors recommend that check this check, but check you do not know what to do even more to do hh lot of money, but not necessarily your disease cured; or cured your disease , but also spent a lot of time and money!
If you have had the experience, then join us for this online interactive and let you see a doctor to take medicine, only not vote for the election of the expensive! because, you is not necessarily the best, not necessarily the best for you:)
Interview Record:
Auto Scroll
Moderator: users Hello everyone, Welcome to Sohu guests chat room. Today We invited three guests are Peking University, Department of Health Policy and Management, Dr. Yang Li; Chinese Medical Association Center for Drug Evaluation's Office of Economics Puming Hui; Beijing Capital Medical University, Professor of Pharmacy with Yu Jin, and users to discuss how to medical treatment more affordable medicine. thank the three came to our studio. most recently the subject of medical treatment is difficult and expensive not only the users concerned, but also are concerned about the industry. Today the three experts are concerned with the drug, especially with economy-related drugs, first please give us a simple analysis of your doctor where the main problem, what are the reasons?
gold have yu: There are several concepts and expensive, one is people think that medical care, earn a month how much money, medical expenses accounted for a large part of the expenditure in this regard that expensive. There are cheaper medicines in the pharmacy to buy medicine in your hospital, this is another one of your concept.
gold have yu: another of your is from the hospital or doctor, professional look, some patients should not use less expensive drugs. paracetamol should be used such as cold medicine, try some common cold medicine can, and sometimes the doctor gave you The antibiotics that the antibiotics, all of a sudden three or four hundred dollars. In the UK some of the hospital, the doctor will let you drink plenty of water to rest, do not give you medicine, his fever was better. our present situation is frequently hit antibiotics, this is really expensive. Some patients must be treated accordingly, they should be drug, the drug had to use a thousand dollars, but not the best medicine can not.
Moderator: your doctor or to distinguish between a subjective or objective reasons.
Yu Jin a professor of medicine at Beijing Capital Medical University, have yu
Gold: One of the keys we solve your doctor is the doctor the proper use of drugs, can not use cheap drugs expensive drugs, this should be addressed. drug prices, falling for a long time people are still not affordable. medical institutions should be unified, how to treat the disease, about how much money, almost everyone's understanding, so you should issue a reasonable medication to resolve.
Puming Hui: rational drug use must be resolved and expensive, especially to improve the knowledge of clinical medicine doctors. Dr. Gao Duan what kind of technology should master, in the low end of what kind of technology should be mastered, general clinical use of drugs must, we must have this awareness, this prescription to eliminate a lot of unnecessary large, especially the abuse of antibiotics. state for abuse of antibiotics reduced the price several times, but the price is not an abuse of antibiotics after it? nothing is small pharmacies selling, hospital or antibiotic abuse. the key is how doctors clinical use of drugs, the most critical is the problem.
Lily: I think your doctor should be understood in two ways, on the one hand, like a teacher who said, feeling very expensive medical costs, which is not the most powerful drugs, the most powerful is the costs of particularly expensive medical equipment. prosthesis, stent related costs are much higher than the price of drugs. In addition to pay respects from the actual doctor Gui relationship between the individual ability to pay. in the UK is very expensive in those countries still see a doctor, why your doctor did not think this argument, not his own pocket, just over six pounds of treatment costs, national health system has to paid, the insurance will pay the money, medical care played a significant role.
urban resident population of our country about 5.6 million people, in fact, basic medical insurance, only 1.5 million, to participate in public health services of five million, most urban residents do not have health insurance , all to his own pocket to see a doctor. participated in the medical insurance business very few people, of course, feel his own pocket to your doctor.
7.4 million farmers in rural areas, the implementation of the new rural cooperative more than three years, end of last year to join the new rural cooperative 4.1 billion people, the coverage is still expanding, the state is now vigorously promoting a new rural cooperative promotion, farmers actually had serious illness, especially after a serious illness is difficult to bear, the new rural cooperative reimbursement only 20% of the low percentage of a few can be reported 70% more than it is up to his own pocket. and expensive combination of these two areas is mainly the one hand, irrational aspects of medical expenses and more, on the other hand would feel if your own pocket, if the insurance to pay, would not be so high the.
Puming Hui Pharmacoeconomic evaluation of the Chinese Medical Association, director
Moderator: One solution is a doctor of rational drug use, we have do not have the data? doctor about medication to patients to pay on how much money you have the statistics?
Lily: can only be estimated, Development and Reform Commission conducted a survey, this one from the drugs, if the drug retail price is a hundred dollars if pharmaceutical companies increase of 30 dollars, distribution channels accounted for 20 dollars and 50 dollars from the hospital too, including the normal fare of 30 dollars is the hospital, five to the hospital costs of enterprises, 15 are doctors of the rebate dollars. If 20% of the costs are unreasonable, the proportion of so doing is quite high, the number is alarming. I generally check out what the total cost of the 2005 national health costs of medicines probably accounts for the over three hundred and thirty billion, including out-patient , the hospital, retail pharmacies, retail pharmacies ratio is 20%, over two hundred billion is the cost of outpatient and inpatient, apportioned according to the NDRC, then the composition of unreasonable medical expenses up to five hundred billion, the number of very amazing.
Moderator: Pharmacoeconomics for advice to the people today is what is the point?
Yang Li: Solving the doctor of your medical expenses from the point of view to reduce the unreasonable medical expenses, some medical cost increase is reasonable, as the technology development of medical technology continues to improve, with people rising demand for health and medical costs were higher than the proportion of GDP, the actual gain in certain parts of it are reasonable, but the irrational part of the is due to circulation caused by the so-called doctors kickbacks caused by the price of drugs also set too high. From this regard, we want to reduce the unreasonable medical expenses, on the one hand can do in terms of pricing, how reasonable pricing, Another is not to reduce the distribution channels, such as the country is now zero difference Beijing drug trial, uniform distribution, the middle of the circulation and how to guide the rational use of doctors, the use of feedback in the form of prescription drugs, or prescription-level guidance to develop the hospital doctors rational drug use .
the other hand from the expansion of health insurance coverage for our country to implement the basic medical insurance for urban residents, including the basic urban residents entered the other goal of the new rural cooperative of rural population with the expansion of 80% this year coverage, the farmers have more or less assured than the original improved. Another aspect of the efforts to strengthen the medical assistance for low-income urban and rural population with basic living security are not, let alone see a doctor to eat drugs, if this town with it, more from the expansion of insurance coverage of some work, you may gradually reduce the current complaint.
Host: Center for Pharmacoeconomic evaluation should be said also involved in the hospital or try to to investigate or improve the way you do that before the hospital now for these drugs serve as a guide you?
Puming Hui: the role is still there, in fact, the concept of pharmacoeconomics is mainly aimed at the country's pharmaceutical prices, or the entire country medical insurance, how to improve the directory in the insurance reimbursement rates and selection of what kind of drugs into the health care directory, and more for this to serve. It may be because the benefits of these aspects of policy implementation, benefits are apparent, including medicines before registration either from the perspective of the enterprise or from the government perspective, there should be methods in economic evaluation of drugs inside. as a research and development enterprise economics with drugs, it is possible not study this drug, it is possible the value created is not as I expect the expected. As a government, the grant is not approved drugs have reference value. If batch came out, still with the same as the original, there is no significant clinical utility improvements. In this case, first of all to eliminate from the original source of drugs for the packaging, changed the formulation to become the new drug to another look out and can not face this problem.
Pharmacoeconomics in international terms, It is the Government end use customers, mainly refers to the special drug pricing, insurance, research and development institutions, including for pharmaceutical companies, enterprises. as a doctor is to enjoy the results, when doctors have the time to get the drugs to enjoy science results, to get the drug at this time or in this range is reasonable, and the rest is another piece of what we do is counter level. What is the prescription level? actually start from the disease, clinical drug development of the manual, according to what what kind of disease, drugs, clinicians using this specification rational use of drugs. both a complete, naturally, from some aspects of clinical medicine so reasonable, but patients can get good results. as the issues raised were the same to enable patients to understand what drugs economics, or in patients compared with the pharmaceutical economics of things, this too difficult, no doubt, put the country were trained experts. we want to do something out of government support can be related, while the policy be implemented, we become a science by the beneficiaries of the policy.
We have done several studies and the departments concerned, including diabetes, psychiatric drugs, urinary tract, according to preliminary results still in the process of discussion. If psychiatric drugs this can finally be in accordance with the results of policy implementation, I think in this regard to the cost for patients who are two-way for the country to save.
Yang Li, Ph.D., Peking University Medicine, Health Policy and Management
Moderator: as you just said, if doctors can be regulated to perform, then there may be appendicitis, as now, about the price of the fixed figure. such treatment of mental illness, probably almost the entire cost of drugs has a fixed number.
Puming Fai: But is not an absolute, can not be fixed that is how much this disease, many diseases, complications, can only be said to be a general range. like me is a diabetic, when the doctor gave me a prescription, I have the choice of drug, when the basis of these results may not be an expensive medicine, the medicine may be cheaper with the point, for the country's fiscal spending, drug spending savings. save the cost out to allow more patients or more patients needed for their use, in order to achieve reasonable. Of course, this is not an absolute solution to China two methods is difficult and expensive problem to see a doctor, but medical treatment can be difficult and expensive as a solution to meet the promulgated by the state drug policy, as a basis for policy and scientific support. as the judge is not the use of drugs, particularly in the physician-patient relationship strained, some say the hospital is not enough compensation, such as the strong use of prescription drugs levels may not have such problems, or indirectly address these issues.
I see a lot of relevant domestic reports, the overall feel, stop-gap measures, which is comprehensive, not a company that can solve this problem, we need concerted efforts , to discuss, the number of new science and technology into in, the original rule of thumb what some of our techniques gradually and quantitative near, it might be a better solution.
Moderator: But you just said, Pharmacoeconomics of our department for the formulation of national prices have meaning, the last two days intense online discussion of a problem with users, the NDRC prices have come down 20 times, how the price was originally developed? was not a good introduction The concept of drug economics do?
gold have yu: NDRC pricing is this: let the country there are two cases of drug prices, a national management to price fixing, a national matter, price liberalization . in the Medicare drug to control the directory, the directory other than the Medicare drug prices on the matter. The drug had a price, and again if there is a principle of management, there is a principle of competitive prices, joint ventures and domestic pharmaceutical companies in the pharmaceutical price Price, a joint venture pharmaceutical drugs people feel good, made a bit cheaper pharmaceutical drugs, the state should control a joint venture pharmaceutical prices down. This is reasonable given the two prices which there are many unreasonable, particularly in China generic drugs. abroad came in a medicine, let's countries do not, how much to sell it how much money, such as selling 50 dollars, I fake it cheaper than it is, people 50 bucks a lot of research and development factors, and I did not 45 dollars into what, the 45 given reasonable unreasonable? certainly unreasonable. Now Development and Reform Commission to push down the prices of these drugs.
drugs your main reasons for two reasons, one big reason is that should not be used medicinal, or cheap medication should be used expensive drugs, this is irrational drug use. there is one already artificially high drug prices, the NDRC before the period of artificially high prices to come down, but no How much pressure down, people did not get benefits. just-to pressure, pressure, as some say, like bun, thin skin did not eat meat, thick-skinned to not eat meat, there are substantial price cuts The pharmaceutical fine, and some pharmaceutical companies suffer. If a drug is not making money, not production, not production, after a no medicine to the people, so this problem is rather complex. Development and Reform Commission is now due to some price adjustment is artificially high prices down, prices are not artificially high even up to go back. Some drugs sold in one hundred three dollars, the NDRC said prices can not rise, in fact, this drug is fine, if the doctor does not produce to not to use, into six dollars much better than using the expensive drugs.
one of the reasons why drugs are drugs in your reasonable pricing, it rationalization, rationalizing, including some drugs have to raise prices, not raise prices did not have to make. This is one expensive drug prices. Another reason you should not use the medicine and the use of expensive drugs, not a standardized thing. The third reason why the irrational use of drugs should not be used used? our country has a tradition of drugs to support medical, hospital there is no money, no money, the President also very anxious. from? from the drugs. that the use of 30 drugs with 50, with 50 by the 80 not so engaged in the wages of workers to open it out. This situation causes the doctor Mei Liangxin open your medicine, there is the doctor said I do not want to open your medicine, but my money wages with this link, I do not open the case, money was gone, wages may without any success. This really is a heavy issue.
issues that need to hold down prices through the investigation, the NDRC your research down, not across the board, the rises should be up, the drop should be reduced. Hospital to support medical internal medicine to find ways to fill the country, and the rest is the rational use of ordinary people. We do not have a standardized national thing.
Moderator: Pharmacoeconomics from a certain extent, the policy is in line with National policy.
gold have yu: I speak a little later you will understand a specific problem, and now all aspects of the country should be standardized, normalized after the unison, the doctor should be so used, the state has such a tube, easier to handle . abroad who controls? insurance company management, you do not follow this to the doctor the next time do not follow this prescription do not you, do not follow this prescription I do not give you money. capitalist countries, insurance companies can not lose money, so the tube was very strict, let the Ministry of Finance in charge of money, the administration of the Ministry of Health, health care management that, the price of your drugs pipe for a long time, the first misfortune is the people his own pocket, the second bad, or country. you no matter the case, health insurance directory have the medicine, the doctor nobody on the open, the 30 dollars, that 50 bucks and then I kind of opened 50, 20 dollars who dig? Medicare dig. State wasted a lot of money, people have money, This is not standard issue.
World Health Organization in developing countries and even basic medicines in the developed countries to implement a policy, originally called the Essential Drugs List, later light directory not found, there are ancillary things, and eventually found a catalog of light No light is supported by the state has no policy does not work, so the implementation of each country have a national essential drugs policy. This policy is not to say one specific policy, but to the concept of large, national leadership Ye Hao, commitment to the people to ensure that drugs can be used on people, bad medicine does not work, have to ensure quality, while also fair use. The World Health Organization, hoping the world standard, our country has not out of this, the beginning of an essential drugs list , and were not supporting something, light a directory. directory is there, people do not have you, foreign insurance companies do not you do not give money, something we do not have this restriction. the rational use of medicines country must have the necessary things, things supporting need to cooperate in all aspects.
such as the World Health Organization has two provisions, one should have a national treatment guidelines, what diseases your country, engage in a spectrum of disease, which disease may be more than the Northwest, Southwest disease which many coastal Which disease multiple, which diagnose how how disease treatment, are not just drug problems. ray tube medication, then you are blind to open the hospital to test a single, ordinary people have to carry, the use should not be used? drug possession to live, but also to promote the above drug loss to fill from the inspection of the above. from the hospital this regard, the country has a basic disease spectrum, according to a standard treatment guidelines developed disease spectrum.
Moderator: Let's just say that the drug economy are also a lot of policy development for the country including drug prices are a lot of restrictive role or the role of a reference. Dr. Yang can not simply tell us about economics for the country or the drugs you are now in the process of implementation of the policy for the countries which have an impact?
Yang Li: Pharmacoeconomics the concept of broad and narrow, broadly understood in all the theories and methods of economics to study the drug market supply side, demand side, the insurer and various economic activities and interventions, are of drug economy study areas. From the narrow sense, Pharmacoeconomic evaluation is only a method of how to evaluate this drug in this treatment, the diagnosis in the end it is good or bad. clinical trials than in the past the advantage is the ability to drug treatment cost and its efficacy and safety were considered together, not only did the original clinical trials is how to consider its efficacy, safety, how, but is an integrated consideration of economics, the cost factors and the effects of factors together, but also people's quality of life indicators such as the effectiveness of the two sides together.
the basis of assessment costs and effects is to combine the most widely used in foreign countries in drug pricing, drug pricing, including pharmaceutical pricing , about 75% of many foreign pharmaceutical companies for drug development, the market prospects will do an estimate for some countries the government is strict in terms of pricing, but also economic evaluation of drugs to pricing. our country is based on cost plus into the way of pricing,
pharmaceutical companies to report their production costs up, the record in the Development and Reform Commission, the NDRC did not know whether the reported cost of up real cost. foreign objects into the drugs widely used method of economic evaluation to drug pricing. In addition, such as diabetes, the countries in the implementation of the insurance, for the same class of drugs are metformin class of drugs developed by a reference price, the insurance company paid to hospitals according to reference price, rather than which drug to follow your actual retail price paid, insurance agencies and hospitals have the right to negotiate, to negotiate the price, the price of reimbursed medicines may be lower than the reference price, but also the methods of economics to take drugs. such as the drug to enter the pharmaceutical reimbursement directory, you can put your and in the same directory to do an evaluation of drugs is higher than that of the drug is less than the drug, if the evaluation results no better than drugs drug effect on the directory, then I do not need this medicine with you.
. also a formulary, doctors have no time to do drug evaluation, research institutions need to undergo a rigorous scientific method to do out of evaluation results announced, available to clinicians to provide to patients, to tell you what the drug is more cost-effective considering the excellent The. effect is a long-term effects, for the chronically ill, there may be associated with quality of life of patients with life. foreign applications mainly in these areas, our country can learn from these experiences, both in pricing or reimbursement directory, Another hospital treatment guidelines and formularies is also very necessary. Pharmacoeconomic evaluation can be used for drug registration in China.
Moderator: Domestic drug mainly used in health care economics, the development of the directory.
Puming Hui: We are doing this work include the compilation of the from the pricing of drugs or from drug registration, as well as the back of medical insurance, if the economic evaluation of drug use into the case, it is useful for policy.
Moderator: Since these two days hang out after the interview notice asking a lot of friends, he usually always eat famotidine, but found both in retail pharmacies or hospitals, the drug prices of products from different manufacturers a lot of difference. If it be considered from his own , eat what medicine is more the right age?
gold have yu: are famotidine, the standard is the same, can cure, since countries have ratified, pharmacopoeia also provides its content in it standards are the same, pharmaceutical companies themselves set the price. In this case, what kind of cheap medicine to see if there is no approval, there is no lot number, home and abroad, the difference is not very pharmaceutical companies and some drugs big, big difference and some drugs. people see which cheaper to buy medicine, also a different brand of medicine, the content should be the same.
Moderator: This requires a national standard.
Puming Hui: Pharmacopoeia standards are, what causes stomach pain stomach pain, stomach problems as long as we can not say with stomach pain, some will be summarized, and some may be returned to acid, acid treatment may use drugs, buy other drugs not need to repeat , saying the right medicine.
gold have yu: to which pharmaceutical drugs to support medical means to do the work of the hospital, the same dollar into 10, he entered the 15 dollars, and gave him kickbacks, so that people pay an extra five money, this is indeed the unreasonable one aspect. hospital which is how I should save my expenses, health insurance is the same objectives, and the 10, the 15, with 10 of the effect is not bad. the original sale 15, it sold 10, I arrived nine price, I do not lose money. about this kind of market economy, competition, the starting point should be the same age, do not engage in dishonest kind of market economy.
Host: From few guests just talking about the drugs economics and our entire relationship between drugs and patients, for the general public is not to say that the economy is low, it should be said also take into account many factors, such as safety factors, the effective factors and so on.
Puming Hui: For the general public is concerned, the economy is actually the concept of dual nature, on the one hand the public should have a basic knowledge, because patients with good medicine that I can use good governance.
chair people: Many people think I have to buy the foreign production of drugs, the more secure.
Puming Hui: This is an area on the other hand strengthen the awareness of rational use of drugs a doctor, this is a two-way. If we say to to enable patients to benefit, both to raise awareness of the patients, while increasing awareness of clinical medicine doctors, two-pronged approach to achieve good results.
Moderator: Professor Jin is the Capital Medical University, you learn medicine itself is born, you that the role of pharmacoeconomics how much the medical?
gold have yu: Pharmacoeconomics before the rise in recent years, the past does not, doctors from various disciplines, medicine, economics, statistics added to the establishment of such a piece of professional, is the new.
countries to develop a standard based on economics, drugs, such as how to treat the disease, diagnosis of whether the Right, the first after what what what what did not effect the re-use, which drugs to patients what good medicine is not good, first choice of what drug? first essential medicines as the country's essential drugs, then the sick say, this drug first used, the drugs have to use, add up to essential drugs. In the basis of essential drugs A medication guide on the first, how to treat diseases which, from the inside out drugs to. medicine's name out, the state produced, how one uses? doctor does not know how to use these drugs does not work, so there must be a prescription-level . treatment guidelines, essential drugs, prescription level of the Trinity, the three countries have such a thing, put up drug norms.
Moderator: Now these three countries have you?
gold have yu: No, the basic With drugs, prescription-level did not, there is no standard treatment guidelines, this is one aspect. World Health Organization to give us, the national essential drug policy which requires a few basic files so that you do not how the treatment guidelines, essential drugs? When we say that is the result of essential drugs investigation, after experts said the doctor, I think what drugs the patient is good, it came from, there is no basis for a guide, so administration is less standardized. This is a foundation.
second base, the state shall have a system or have a request, asked the doctor to do in accordance with this. With guide to what the status of this guide, with the essential drugs list, what is the status of essential medicines list, and must have a specification, just like the insurance companies, that are not covered does not give you the money. medical insurance also has a base directory, its directory with the drug list is different, that directory is a directory of public health. Shanghai in Shanghai's public health directory, Nanjing their public health directory, pick it from the directory, 29, 30 there are 15 provinces and autonomous regions have the drug even more. At that time no drugs economics, so the two directories out, in the end who will listen Who? their own way. This directory is how to choose medicine? should also be considered reasonable and unreasonable, there is an economic factor in it.
Australia, a typical example, two drugs from drug to compare the economic point of view, then, a is the TPA, one is streptokinase, can treatment of cerebral thrombosis, the two drugs as essential drugs, drug price difference between these two relatively poor, relatively cheap streptokinase, TPA is more expensive. But more people to save TPA , rescue more people came, a little lower streptokinase available chlorine. should be said that expensive like that of economics and how to measure the effect of drugs is the number of people saved, or the person contribution to the country into account, factor out the more investment into the money to cure the sick, and how these two trade-offs, such a trade-off, then came to save the high percentage, this person may also be a lot of value created, of course, the good, it should be considered an essential element. There are some small hospitals can not buy a year of funding for much of this medicine, in order to save more than 10% of the people, but above all spent on this, other patients also Kan Bukan? hospital itself also has a bear economy conditions. both from the cheaper drugs, your consideration, but also from the quality of life, etc. contributed to weigh all aspects, and finally to consider the economic effect of which the most suitable drug.
Pharmacoeconomics Essential Drugs List for countries to develop Ye Hao, do some research work to help the Government to consider to solve the problem, it is useful. So Pharmacoeconomics is a professional thing, we are now being applied. the people inside the brain, or that doctors need to be the result of the experimental results do seen on the line, do not have to do it. The most intuitive is the ordinary people to consider the price of drugs from this, rational drug use is on the one hand, the use should not be used. The use of this medicine, and that also has a joint venture with domestic and imported , the domestic pharmaceutical companies out there are different not the same as drug prices, our country should promote the use of cheaper drugs.
Moderator: You just said that when doctors use, especially as antibiotics, starting from the basic use , I use penicillin, penicillin antibiotics, not pulls more efficient.
Puming Hui: In the actual application of them to choose more expensive drugs, when abroad in the choice of antibiotics, first with penicillin, higher than the Dean of penicillin, many drugs need to sign to use, not a doctor able to open prescription. This is a clinical problem of rational use of medicines doctors.
gold have yu: Let the state should have a requirement, how should I treat what drug. such as said earlier that the treatment of cerebral thrombosis can use this to use that, we generally use the basic drugs can be expensive, with his own money. like buying a car, some people buy Xiali, was to buy Mercedes-Benz, the rich can buy Mercedes-Benz, there is no money to buy Xiali. If your willing to pay 50%, it can also use your medicine, do not affect our use of cheaper drugs. cheap drugs to go into the directory, streptokinase with domestic and imported .
me give a simple example, a variety of antihypertensive drugs, Plymouth classes of drugs are now a dozen, from economics to consider there is no difference, no difference in the results, almost, this is pharmaceutical companies to engage in brand name, I synthesized the drug, which changed the above synthesis of another change, the basic function does not differ essentially a way. For if you eat fruit bread, he ate another kind of bread, there is a little bit of difference, but This difference is not significant. You eat bread to eat fruit, you eat other bread is eaten. The Plymouth Plymouth that can cure disease, the difference is not just a matter of habit.
take pharmaceutical companies for joint ventures, an effective drug prices can be two to three times worse. The most expensive is the two most expensive is four. domestic pharmaceutical companies and joint venture pharmaceutical price is not only a thin double, and some poor ten times, drug effect is basically the same, you should use what? antipyretics one hundred Ning is imported, anti-inflammatory drugs, known as paracetamol in our country, our country is a major exporter of raw materials, finished abroad to come back. our country to sell five cents a piece, four-five cents is the foreign one, they sell 1.6 yuan a first, I went to Concord to ask that the drugs have made? not. sold a total of only five cents, how much I make that 1.6 yuan . The same drugs have a different price, the same can cure disease, you are willing to spend more money with your medicine, you do not want to spend more money to buy cheaper drugs.
Moderator: State should take into account the large interests of the majority.
gold have yu: Pharmacoeconomics from a different angle to give people a point of view, the same drug, domestic or imported with the joint venture with the difference of the lot, made in China will not suffer by not will be a mess. our country nobody in this matter, Canada is aware of this problem, the insurance company is also the habit of buying two of the drugs and buy four of medicine, you can not say that people do not have four of the drugs. Later, the introduction of a requirement , any class with a Plymouth drugs, no matter what I give you with the reimbursement of two dollars, four dollars you are willing to pay for their own use of two dollars, do not want to use to buy two of the four drugs. This setting is through the surveys, not to say casually given, this year five million province. just when the introduction of this policy has many problems, because patients with hypertension to two dollars for medicine, blood pressure and go up. people ready , more than three months also see a doctor, the hospital does not work, after three months on the right, one year festival ...
No comments:
Post a Comment